To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms242115925 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Giusi Ianiro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Territory, University of Molise, 86090 Pesche, Italy. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Metabolic Syndrome, Hypertension. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Many pathological conditions, including obesity, diabetes, hypertension, heart disease, and cancer, are associated with abnormal metabolic states. The progressive loss of metabolic control is commonly characterized by insulin resistance, atherogenic dyslipidemia, inflammation, central obesity, and hypertension, a cluster of metabolic dysregulations usually referred to as the “metabolic syndrome”. Recently, nutraceuticals have gained attention for the generalized perception that natural substances may be synonymous with health and balance, thus becoming favorable candidates for the adjuvant treatment of metabolic dysregulations. Among nutraceutical proteins, lactoferrin (Lf), an iron-binding glycoprotein of the innate immune system, has been widely recognized for its multifaceted activities and high tolerance. As this review shows, Lf can exert a dual role in human metabolism, either boosting or resetting it under physiological and pathological conditions, respectively. Lf consumption is safe and is associated with several benefits for human health, including the promotion of oral and gastrointestinal homeostasis, control of glucose and lipid metabolism, reduction of systemic inflammation, and regulation of iron absorption and balance. Overall, Lf can be recommended as a promising natural, completely non-toxic adjuvant for application as a long-term prophylaxis in the therapy for metabolic disorders, such as insulin resistance/type II diabetes and the metabolic syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Territory, University of Molise, 86090 Pesche, Italy.
- Department of Public Health and Infectious Diseases, University of Rome La Sapienza, 00185 Rome, Italy.
ORCID-Profile: Luigi Rosa, Giovanni Musci, Antimo Cutone
Zitieren
APA
Ianiro, G., Niro, A., Rosa, L., Valenti, P., Musci, G., & Cutone, A. (2023). To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242115925
Vancouver
Ianiro G, Niro A, Rosa L, Valenti P, Musci G, Cutone A. To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242115925
BibTeX
@article{Ianiro2023,
author = {Ianiro, Giusi and Niro, Antonella and Rosa, Luigi and Valenti, Piera and Musci, Giovanni and Cutone, Antimo},
title = {To Boost or to Reset: The Role of Lactoferrin in Energy Metabolism},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms242115925}
}
EUVIMED